14 August 2018 - As progress in oncology care is advancing faster than ever -- especially due to the work of artificial intelligence and real world data for clinical decision making -- it can be difficult to distinguish what is hype and what will be realised in the near future.

At this year’s American Society of Clinical Oncology conference, the big trend of 2018 was “less is more.”  Two new clinical best practices made international headlines by recommending areas where people with cancer could safely avoid difficult, risky and costly treatment. The first being that most women in the early stages of breast cancer could skip chemotherapy with guidance from a diagnostic test; the second is that many people with advanced kidney cancer do not need surgery. 

Both studies were conducted through clinical trials, but I am confident that similarly minimalist findings are on the horizon using AI analysis of existing real world data.

Read Forbes magazine article